0000899243-22-029864.txt : 20220826 0000899243-22-029864.hdr.sgml : 20220826 20220826163058 ACCESSION NUMBER: 0000899243-22-029864 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220705 FILED AS OF DATE: 20220826 DATE AS OF CHANGE: 20220826 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Menzel Garry E CENTRAL INDEX KEY: 0001556064 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38811 FILM NUMBER: 221205662 MAIL ADDRESS: STREET 1: C/O REGULUS THERAPEUTICS INC. STREET 2: 3545 JOHN HOPKINS COURT SUITE 210 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TCR2 THERAPEUTICS INC. CENTRAL INDEX KEY: 0001750019 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 474152751 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-949-5200 MAIL ADDRESS: STREET 1: 100 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-07-05 0 0001750019 TCR2 THERAPEUTICS INC. TCRR 0001556064 Menzel Garry E C/O TCR2 THERAPEUTICS 100 BINNEY STREET CAMBRIDGE MA 02142 1 1 0 0 President & CEO Common Stock 2022-07-05 4 G 0 84527 0.00 D 0 I See Footnote Common Stock 2022-07-05 4 G 0 84527 0.00 A 84527 I See Footnote Common Stock 2022-07-05 4 G 0 48202 0.00 D 132730 D Common Stock 2022-07-05 4 G 0 48202 0.00 A 132729 I See Footnote Common Stock 2022-07-05 4 G 0 132730 0.00 D 0 D Common Stock 2022-07-05 4 G 0 132730 0.00 A 132730 I See Footnote The reporting person is voluntarily reporting the disposition for no consideration on July 5, 2022 of 84,527 shares of common stock held by the reporting person, as Trustee of the Garry E. Menzel and Mary E. Henshall Family Trust, under instrument of trust dated July 29, 2010, to the Garry E. Menzel Revocable Trust of 2022, under Indenture of Trust dated April 45, 2022 (the "Menzel Trust"). The reporting person is the trustee of the Menzel Trust and may be deemed to beneficially own these securities. The reporting person and members of his immediate family are the sole beneficiaries of the Menzel Trust. The reporting person is voluntarily reporting the disposition for no consideration on July 5, 2022 of 48,202 shares of common stock held by the reporting person to the Menzel Trust. The reporting person is voluntarily reporting the disposition for no consideration on July 5, 2022 of 132,730 shares of common stock held by the reporting person to the Mary E. Henshall Revocable Trust of 2022, under Indenture of Trust dated April 5, 2022 (the "Henshall Trust"). The reporting person's spouse is the trustee of the Henshall Trust, and as such the reporting person may be deemed to beneficially own these securities. The reporting person and members of his immediate family are the sole beneficiaries of the Henshall Trust. Margaret Siegel as Attorney-In-Fact 2022-08-26